Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments 中文版
18 Aug, 2025 (Monday)

            
RIMAG GROUP(2522)
Analysis:
RIMAG Group primarily provides medical imaging services, imaging solution services, and RIMAG Cloud services in China. It is the only medical imaging platform operator and manager in China that offers diversified imaging services and value across the entire medical imaging industry chain. The company listed on the Hong Kong Stock Exchange on June 7, 2024, becoming the “first medical imaging service stock in China.” The Group’s imaging center services aim to address pain points in the medical imaging industry, enabling and balancing the allocation of high-quality medical imaging resources to form a network of chain medical imaging centers. The imaging solution services are designed to enhance clients’ ability to serve patients through imaging empowerment solutions. RIMAG Cloud services help medical institutions reduce labor costs, standardize workflows, and achieve data-driven management, thereby improving their service capabilities and enhancing the patient experience.
Following its successful entry into the capital market, the Group will continue to use the funds raised to expand its imaging center network, seek strategic partnerships and investment opportunities along the industry chain, and consolidate its leading position in China’s third-party medical imaging services. Additionally, the company will actively pursue overseas expansion, focusing on integrating its superior imaging solution services to form core imaging service capabilities for international markets, aiming to unlock new growth opportunities.
For the year ended December 31, 2024, the Group developed 18 new imaging center projects and successfully operationalized 17 imaging center projects with high quality. As of December 31, 2024, its medical imaging center network extensively covered 16 provinces, autonomous regions, and municipalities in China, with a total of 106 operational imaging centers forming a large-scale, intensive operational matrix. In 2024, the Group established an overseas business division, building a business expansion network covering Hong Kong, Macau, Southeast Asia, the Middle East, and Africa. It adopted a “product + service + brand” trinity model to explore overseas markets. Looking ahead, the Group plans to continue developing regional shared imaging centers, strategically selecting regions with relatively imbalanced medical resources for resource integration and prioritized investment. It also plans to further develop specialized medical consortium imaging centers and operational management-type imaging centers in regions where imaging centers have already been established. In high-tier cities with large populations, high consumption levels, and diverse demand, the Group will focus on the refined operation and service enhancement of flagship imaging centers. It will also actively explore strategic cooperation with internet hospitals (e.g., JD Health) to enable online appointment scheduling, with RIMAG imaging centers providing offline examination delivery to broaden patient access channels. Under the guidance of internet hospital demand, the Group will consider the strategic placement of flagship imaging centers and further deepen the medical consortium business layout of flagship imaging centers, incorporating more small and medium-sized medical institutions in the region into the flagship imaging center service network. This will expand coverage of healthcare institutions (H-end) and provide more differentiated imaging diagnostics and imaging solution services.
Strategy:
Buy-in Price: $18.80, Target Price: $21.00, Cut Loss Price: $17.70


FOXCONN INDUSTRIAL(601138.CH)
Analysis:
The Company is a world leading professional design and manufacturing service provider for communication network equipment, cloud service equipment, precision tools and industrial robots, providing customers with intelligent manufacturing services for new forms of electronic equipment products with the industrial Internet platform as the core. The Company released its semi annual report for 2025,with a sales revenue of RMB360.76 billion yuan in 2025H1, hoh+5.16%,yoy+35.58% and a net profit attributable to the parent company of 12.113 billion yuan, hoh-16.33%,yoy+38.61%. In 2025, many large cloud service providers around the world continued to expand their capital expenditures on AI infrastructure construction, and their investment in AI computing power accelerating, driving the Company’s overall server revenue of 2Q25 to increase by more than 50%, cloud service provider server revenue to increase by more than 150% year-on-year, and AI to increase by more than 60% yoy. The MGMT expects the strong momentum to continue in 25H2.
Strategy:
Buy-in Price: RMB42.68, Target Price: RMB50.20, Cut Loss Price: RMB38.50



Great Star Industrial (002444.CH) - Breakthrough in Power Tools

Company profile

The Company was established in 1993, starting with OEM of hand tools. In 2009, it launched its first proprietary brand, Workpro, and began transitioning from original design manufacturer (ODM) to original brand manufacturer (OBM). At the same time, it continued overseas acquisitions to expand its brand portfolio, driving continuous growth in scale. Currently, the Company's products are mainly targeted at Europe and the United States. In 2024, overseas revenue accounted for 95%. Its products mainly include hand tools, power tools and industrial tools, with revenue of RMB10.07 billion (RMB, the same below), RMB1.44 billion and RMB3.23 billion, respectively. Among them, OBM and ODM revenue accounted for 47.92% and 51.67%.

Investment Summary

Steady Growth in Results
In 2024, the Company achieved revenue of approximately RMB14.80 billion, up 35.37% yoy; net profit attributable to the parent company of RMB2.30 billion, up 36.18% yoy; and a gross margin of 32.01%. Over the past five years since 2019, revenue and net profit have recorded an average growth rate of 17.5% and 20.6%, respectively.

On July 10, the Company issued a result forecast, expecting H1 2025 net profit attributable to the parent company to be RMB1.25-1.37 billion, representing an estimated increase of 5%-15%; net profit attributable to the parent company excluding non-recurring items is expected to be RMB1.27-1.39 billion, up approximately 5%-15%, equivalent to a Q2 net profit attributable to the parent company growth midpoint of 9.2%, better than market expectations.

Although U.S. tariffs negatively impacted production capacity utilization for approximately 40 days in Q2, affecting order delivery and revenue, it is expected that Q2 revenue compared with the same period last year remained almost the same. However, the Company improved its gross margin through cross-border e-commerce sales and increased sales of new products, particularly power tools. As a result, Q2 net profit attributable to the parent company is expected to grow, demonstrating strong growth potential.

Breakthrough in Power Tools
According to Frost & Sullivan, from 2022 to 2026, the global CAGR for power tools will exceed 6%, while the CAGR for hand tools will be 3%-4%, with powered products significantly outperforming non-powered ones. Since 2021, the Company has positioned power tools as a strategic business, and in 2024 achieved breakthroughs in 20V lithium battery tools in mainstream markets. It subsequently announced two major international retail customer orders for lithium battery power tools and related accessories, with total annual procurement values equivalent to no less than USD30 million and USD15 million, respectively. Notably, the first order required production and delivery in Vietnam for the U.S. market, marking the Company's first power tool order produced and delivered outside China, and validating its global supply capabilities with top-tier clients. The second order, from Europe, marked the Company's debut in the European power tools market.

Global Capacity Layout to Respond Quickly to Market Demand

Since 2018, the Company has accelerated its overseas capacity layout through self-built plants in Southeast Asia and acquisitions in Europe and the U.S. Currently, it operates 23 production bases worldwide, including 11 in China, 3 in Southeast Asia, 6 in Europe, and 3 in the U.S. The global supply chain system not only improves responsiveness to sudden market demands but also strengthens resilience against global trade barriers. In Q2 2025, due to the impact of the U.S. "Reciprocal Tariffs" policy, production capacity was restricted for about 40 days, significantly affecting order delivery and revenue. However, with the Vietnam production base, the Company partially avoided tariff risks. Now, the third phase of the Vietnam base is already in operation, and the fourth phase is under construction, with full coverage of Southeast Asia's shipments to the U.S. expected by the end of 2025. This arrangement reduces cost pressures from China-U.S. trade frictions and lays a solid foundation for future growth. In addition, the 20% tariff agreement between Vietnam and the U.S., which is lower than China's export tariff to the U.S., will help further consolidate the Company's competitiveness in global markets.

Investment Thesis

The Company's revenue is concentrated in Europe and the U.S., and in the future, it will leverage capacity relocation to establish a complete trade chain of "R&D in China -- Manufacturing in Southeast Asia -- Sales in Europe and the U.S." We are optimistic about the long-term development of the Company and expect EPS to be 2.04/2.62/3.26 yuan respectively for 2025/2026/2027. We offer a target price of 39.4 yuan, respectively 19.3/15/12.1x P/E for 2025/2026/2027, and an "Accumulate" rating.

"P/E

Risk Factors

1) Progress of new production line is below expectations;
2) Electric power tools sales fall short of expectations;
3) Macroeconomic downturn affects product demand;
4) Sharply rising raw material prices or sharply falling product prices.

Financial Data

"Financial

(Closing price as at 14 August 2025)

Download PDF Version Here...




Recommendation on 18-8-2025
RecommendationAccumulate (Initiation)
Price on Recommendation Date$ 34.620
Suggested purchase priceN/A
Target Price$ 39.400
Writer Info
Zhang Jing
(Research Analyst)
Tel: + 86 21-6351 2939
Email:
zhangjing@phillip.com.cn

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

版權所有, 翻印必究。

Copyright(C) 2025 Phillip Securities (HK) Ltd. All Rights Reserved.